Thu, October 13, 2022
Wed, October 12, 2022
Tue, October 11, 2022
Mon, October 10, 2022
Sun, October 9, 2022
Fri, October 7, 2022

Matthew Harrison Maintained (ABBV) at Buy with Decreased Target to $185 on, Oct 11th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. th-decreased-target-to-185-on-oct-11th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Matthew Harrison of Morgan Stanley, Maintained "AbbVie Inc." (ABBV) at Buy with Decreased Target from $188 to $185 on, Oct 11th, 2022.

Matthew has made no other calls on ABBV in the last 4 months.



There are 11 other peers that have a rating on ABBV. Out of the 11 peers that are also analyzing ABBV, 5 agree with Matthew's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Steve Chesney of "Atlantic Equities" Maintained at Hold with Decreased Target to $162 on, Monday, August 1st, 2022
  • Carter Gould of "Barclays" Maintained at Hold with Decreased Target to $160 on, Monday, August 1st, 2022
  • Colin Bristow of "UBS" Maintained at Hold with Decreased Target to $146 on, Monday, August 1st, 2022
  • Luisa Hector of "Berenberg" Reiterated at Hold and Held Target at $135 on, Friday, July 15th, 2022
  • Geoff Meacham of "B of A Securities" Reiterated at Hold and Held Target at $156 on, Tuesday, June 21st, 2022


These are the ratings of the 6 analyists that currently disagree with Matthew


  • David Risinger of "SVB Leerink" Maintained at Sell with Decreased Target to $135 on, Friday, September 30th, 2022
  • Terence Flynn of "Morgan Stanley" Reiterated at Buy and Held Target at $188 on, Wednesday, September 14th, 2022
  • Jasper Hellweg of "Argus Research" Maintained at Strong Buy with Decreased Target to $155 on, Wednesday, August 24th, 2022
  • Gary Nachman of "BMO Capital" Maintained at Buy with Decreased Target to $170 on, Monday, August 1st, 2022
  • Christopher Raymond of "Piper Sandler" Maintained at Buy with Decreased Target to $155 on, Monday, August 1st, 2022
  • Robyn Karnauskas of "Truist Securities" Reiterated at Strong Buy and Held Target at $160 on, Friday, July 29th, 2022

Publication Contributing Sources